{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:51:10Z","timestamp":1776199870368,"version":"3.50.1"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH, Department of Health and Human Services"},{"name":"Research Support Services for the Division of AIDS"},{"DOI":"10.13039\/100011886","name":"Dubai Harvard Foundation for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011886","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH NIAID","award":["1R01AI104589"],"award-info":[{"award-number":["1R01AI104589"]}]},{"name":"TB SMART Study (TB Surrogate Markers for Assessing Response to Treatment)"},{"name":"CDC TB Trials Consortium"},{"name":"NIH NIAID","award":["R24 AI 118397"],"award-info":[{"award-number":["R24 AI 118397"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1164\/rccm.201806-1053pp","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T16:14:11Z","timestamp":1539879251000},"page":"564-571","source":"Crossref","is-referenced-by-count":25,"title":["Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection"],"prefix":"10.1093","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-3305","authenticated-orcid":false,"given":"Salmaan","family":"Keshavjee","sequence":"first","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Harvard Medical School Center for Global Health Delivery\u2013Dubai, Dubai, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Amanullah","sequence":"additional","affiliation":[{"name":"The Indus Hospital, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[{"name":"University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Chaisson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Dobos","sequence":"additional","affiliation":[{"name":"Colorado State University, Fort Collins, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Fox","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Gordon","sequence":"additional","affiliation":[{"name":"South African Medical Research Council, Cape Town, Western Cape, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke","family":"Hesseling","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoi","family":"Le Van","sequence":"additional","affiliation":[{"name":"National Lung Hospital, Hanoi, Vietnam"},{"name":"National TB Program in Vietnam, Hanoi, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bavesh","family":"Kana","sequence":"additional","affiliation":[{"name":"University of Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa"},{"name":"Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal","family":"Khuller","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Lewinsohn","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, Oregon"},{"name":"Portland VA Medical Center, Portland, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Lewinsohn","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philiana Ling","family":"Lin","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenette Lin","family":"Lu","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Owen","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, England"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Protopopova","sequence":"additional","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyothi","family":"Rengarajan","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rubin","sequence":"additional","affiliation":[{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmini","family":"Salgame","sequence":"additional","affiliation":[{"name":"Rutgers University, New Brunswick, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Schurr","sequence":"additional","affiliation":[{"name":"McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Seddon","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Swindells","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Tobin","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarir","family":"Udwadia","sequence":"additional","affiliation":[{"name":"Hinduja Hospital & Research Center, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[{"name":"University of Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa"},{"name":"Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Rustomjee","sequence":"additional","affiliation":[{"name":"Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payam","family":"Nahid","sequence":"additional","affiliation":[{"name":"University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"2026030321260267200_bib1","author":"World Health Organization"},{"key":"2026030321260267200_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(14)61811-0","article-title":"The burden of tuberculosis disease in children--authors\u2019 reply","volume":"384","author":"Jenkins","year":"2014","journal-title":"Lancet"},{"key":"2026030321260267200_bib3","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"2026030321260267200_bib4","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"2026030321260267200_bib5","first-page":"373","article-title":"Latent tuberculosis infection\u2013revisiting and revising concepts","volume-title":"Tuberculosis (Edinb)","author":"Salgame","year":"2015"},{"key":"2026030321260267200_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753465813503028","article-title":"Treatment of latent tuberculosis infection","volume":"7","author":"Parekh","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"2026030321260267200_bib7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"2026030321260267200_bib8","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2026030321260267200_bib9","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"20","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026030321260267200_bib10","first-page":"920","article-title":"Tuberculosis in Alaska, 1970: the continued decline of the tuberculosis epidemic","volume":"105","author":"Kaplan","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"2026030321260267200_bib11","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2026030321260267200_bib12","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis: a general review","volume-title":"Bibl Tuberc","author":"Ferebee","year":"1970"},{"key":"2026030321260267200_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/338342","article-title":"Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection","volume":"185","author":"Lillebaek","year":"2002","journal-title":"J Infect Dis"},{"key":"2026030321260267200_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"2026030321260267200_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri3259","article-title":"The immunological life cycle of tuberculosis","volume":"12","author":"Ernst","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026030321260267200_bib16","doi-asserted-by":"crossref","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","article-title":"Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease","volume":"13","author":"Scriba","year":"2017","journal-title":"PLoS Pathog"},{"key":"2026030321260267200_bib17","doi-asserted-by":"crossref","first-page":"242, author reply 242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"2026030321260267200_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2004-829504","article-title":"Latent tuberculosis infection","volume":"25","author":"Nuermberger","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"2026030321260267200_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: myths, models, and molecular mechanisms","volume":"78","author":"Dutta","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"2026030321260267200_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1513\/AnnalsATS.201511-750ED","article-title":"\u201cLatent tuberculosis infection\u201d is a term that should go dormant, and the significance of latent tuberculosis should be rethought","volume":"13","author":"Schraufnagel","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026030321260267200_bib21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.0711159105","article-title":"Mycobacterial persistence requires the utilization of host cholesterol","volume":"105","author":"Pandey","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321260267200_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1462-5822.2005.00648.x","article-title":"Carbon metabolism of intracellular bacteria","volume":"8","author":"Mu\u00f1oz-El\u00edas","year":"2006","journal-title":"Cell Microbiol"},{"key":"2026030321260267200_bib23","doi-asserted-by":"crossref","first-page":"e1001065","DOI":"10.1371\/journal.pbio.1001065","article-title":"Metabolic regulation of mycobacterial growth and antibiotic sensitivity","volume":"9","author":"Baek","year":"2011","journal-title":"PLoS Biol"},{"key":"2026030321260267200_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrmicro1065","article-title":"Tuberculosis - metabolism and respiration in the absence of growth","volume":"3","author":"Boshoff","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"2026030321260267200_bib25","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1316894110","article-title":"Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression","volume":"110","author":"Cunningham-Bussel","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321260267200_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrmicro3349","article-title":"Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence","volume":"12","author":"Gouzy","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2026030321260267200_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tube.2008.08.004","article-title":"Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model","volume":"89","author":"Kesavan","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321260267200_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tube.2003.12.006","article-title":"Gene expression profile of Mycobacterium tuberculosis in a non-replicating state","volume":"84","author":"Muttucumaru","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321260267200_bib29","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect Immun"},{"key":"2026030321260267200_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-014-0103-7","article-title":"Interaction of pattern recognition receptors with Mycobacterium tuberculosis","volume":"35","author":"Mortaz","year":"2015","journal-title":"J Clin Immunol"},{"key":"2026030321260267200_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"2026030321260267200_bib32","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.ppat.1001307","article-title":"Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages","volume":"7","author":"Portevin","year":"2011","journal-title":"PLoS Pathog"},{"key":"2026030321260267200_bib33","doi-asserted-by":"crossref","first-page":"e23870","DOI":"10.1371\/journal.pone.0023870","article-title":"Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles","volume":"6","author":"Krishnan","year":"2011","journal-title":"PLoS One"},{"key":"2026030321260267200_bib34","doi-asserted-by":"crossref","first-page":"e67277","DOI":"10.1371\/journal.pone.0067277","article-title":"Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response","volume":"8","author":"Carmona","year":"2013","journal-title":"PLoS One"},{"key":"2026030321260267200_bib35","doi-asserted-by":"crossref","first-page":"e1000034","DOI":"10.1371\/journal.ppat.1000034","article-title":"The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis","volume":"4","author":"Caws","year":"2008","journal-title":"PLoS Pathog"},{"key":"2026030321260267200_bib36","article-title":"Screening for latent tuberculosis infection in adults: an evidence review for the U.S. Preventive Services Task Force","author":"Kahwati"},{"key":"2026030321260267200_bib37","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1172\/JCI83279","article-title":"Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response","volume":"125","author":"Adekambi","year":"2015","journal-title":"J Clin Invest"},{"key":"2026030321260267200_bib38","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"2026030321260267200_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"2026030321260267200_bib40","article-title":"GC6-74 and ACS cohort study groups. Four-gene pan-African blood signature predicts progression to tuberculosis","author":"Suliman"},{"key":"2026030321260267200_bib41","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1074\/mcp.M116.064733","article-title":"Human immunoglobulin heavy gamma chain polymorphisms: molecular confirmation of proteomic assessment","volume":"16","author":"Dambrun","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"2026030321260267200_bib42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccell.2018.02.009","article-title":"Complex interplay between epitope specificity and isotype dictates the biological activity of anti-human CD40 antibodies","volume":"33","author":"Yu","year":"2018","journal-title":"Cancer Cell"},{"key":"2026030321260267200_bib43","doi-asserted-by":"crossref","first-page":"e1006987","DOI":"10.1371\/journal.ppat.1006987","article-title":"HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies","volume":"14","author":"Richardson","year":"2018","journal-title":"PLoS Pathog"},{"key":"2026030321260267200_bib44","doi-asserted-by":"crossref","first-page":"e7881","DOI":"10.15252\/msb.20177881","article-title":"High-resolution definition of humoral immune response correlates of effective immunity against HIV","volume":"14","author":"Alter","year":"2018","journal-title":"Mol Syst Biol"},{"key":"2026030321260267200_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/intimm\/dxx041","article-title":"Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review","volume":"29","author":"Kaifu","year":"2017","journal-title":"Int Immunol"},{"key":"2026030321260267200_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"2026030321260267200_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/eji.201646658","article-title":"Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed\/infected with Mycobacterium tuberculosis","volume":"47","author":"Du Plessis","year":"2017","journal-title":"Eur J Immunol"},{"key":"2026030321260267200_bib48","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321260267200_bib49","doi-asserted-by":"crossref","first-page":"e0163848","DOI":"10.1371\/journal.pone.0163848","article-title":"Cytokine patterns in tuberculosis infection; IL-1ra, IL-2 and IP-10 differentiate borderline QuantiFERON-TB samples from uninfected controls","volume":"11","author":"Wergeland","year":"2016","journal-title":"PLoS ONE"},{"key":"2026030321260267200_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2026030321260267200_bib51","doi-asserted-by":"crossref","first-page":"112907","DOI":"10.18632\/oncotarget.22889","article-title":"Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"2026030321260267200_bib52","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/infdis\/jiy006","article-title":"Prospective discrimination of controllers from progressors early after low-dose Mycobacterium tuberculosis infection of cynomolgus macaques using blood RNA signatures","volume":"217","author":"Thompson","year":"2018","journal-title":"J Infect Dis"},{"key":"2026030321260267200_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321260267200_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12014-017-9156-y","article-title":"Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum","volume":"14","author":"Mehaffy","year":"2017","journal-title":"Clin Proteomics"},{"key":"2026030321260267200_bib55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tube.2014.10.010","article-title":"Deciphering the role of exosomes in tuberculosis","volume":"95","author":"Kruh-Garcia","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321260267200_bib56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321260267200_bib57","doi-asserted-by":"crossref","first-page":"O230","DOI":"10.1111\/1469-0691.12383","article-title":"Differential gene expression of activating Fc\u03b3 receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity","volume":"20","author":"Sutherland","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2026030321260267200_bib58","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030321260267200_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030321260267200_bib60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026030321260267200_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"2026030321260267200_bib62","article-title":"One month of rifapentine\/isoniazid to prevent TB in people with HIV: BRIEF-TB\/A5279","author":"Swindells"},{"key":"2026030321260267200_bib63","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciu849","article-title":"Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB\/HIV in Rio (THRio) study","volume":"60","author":"Golub","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026030321260267200_bib64","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"key":"2026030321260267200_bib65"},{"key":"2026030321260267200_bib66","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026030321260267200_bib67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/joim.12256","article-title":"Inflammation and tuberculosis: host-directed therapies","volume":"277","author":"Zumla","year":"2015","journal-title":"J Intern Med"},{"key":"2026030321260267200_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026030321260267200_bib69","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S1473-3099(16)00070-0","article-title":"Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers","volume":"16","author":"Wallis","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026030321260267200_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5588\/ijtld.17.0515","article-title":"Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study","volume":"22","author":"Rajoli","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321260267200_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5588\/ijtld.17.0486","article-title":"Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges","volume":"22","author":"Swindells","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321260267200_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/33.2.273","article-title":"Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer","volume":"33","author":"Kailasam","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"2026030321260267200_bib73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/33.2.265","article-title":"Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers","volume":"33","author":"Gangadharam","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"2026030321260267200_bib74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"2026030321260267200_bib75","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321260267200_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5588\/ijtld.14.0078","article-title":"Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention","volume":"19","author":"Reid","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321260267200_bib77","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"2026030321260267200_bib78","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","article-title":"Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study","volume":"2","author":"Dodd","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2026030321260267200_bib79","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321260267200_bib80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QCO.0b013e3283529af9","article-title":"Current understanding of the immune response to tuberculosis in children","volume":"25","author":"Basu Roy","year":"2012","journal-title":"Curr Opin Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/199\/5\/564\/67120982\/ajrccm_199_5_564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/199\/5\/564\/67120982\/ajrccm_199_5_564.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:26:16Z","timestamp":1772591176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/199\/5\/564\/8497862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":80,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3,1]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201806-1053pp","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,3,1]]}}}